LabCorp Extends Tender Offer for All Outstanding Shares of Monogram Biosciences, Inc. Read more about LabCorp Extends Tender Offer for All Outstanding Shares of Monogram Biosciences, Inc.
Laboratory Corporation of America(R) Holdings Announces 2009 Second Quarter Results Read more about Laboratory Corporation of America(R) Holdings Announces 2009 Second Quarter Results
LabCorp's Acquisition of Monogram Biosciences, Inc. Clears Antitrust Review Read more about LabCorp's Acquisition of Monogram Biosciences, Inc. Clears Antitrust Review
LabCorp Redeems All Outstanding Liquid Yield Option(TM) Notes Due 2021 and $369.1 Million Principal Amount at Maturity of Zero Coupon Convertible Subordinated Notes Due 2021 Read more about LabCorp Redeems All Outstanding Liquid Yield Option(TM) Notes Due 2021 and $369.1 Million Principal Amount at Maturity of Zero Coupon Convertible Subordinated Notes Due 2021
LabCorp Commences Cash Tender Offer for All Outstanding Shares of Monogram Biosciences, Inc. Read more about LabCorp Commences Cash Tender Offer for All Outstanding Shares of Monogram Biosciences, Inc.
LabCorp Enters Definitive Agreement to Acquire Monogram Biosciences, Inc. Read more about LabCorp Enters Definitive Agreement to Acquire Monogram Biosciences, Inc.
LabCorp is Scheduled to Present at the William Blair & Company 29th Annual Growth Stock Conference Read more about LabCorp is Scheduled to Present at the William Blair & Company 29th Annual Growth Stock Conference
LabCorp to Strengthen Capital Structure by Redeeming Convertible Debt Read more about LabCorp to Strengthen Capital Structure by Redeeming Convertible Debt
LabCorp is Scheduled to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference Read more about LabCorp is Scheduled to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference
LabCorp Announces David P. King Elected Chairman of the Board Read more about LabCorp Announces David P. King Elected Chairman of the Board
